• iDesign worked with JHP Pharmaceuticals to develop a program of requirements to support the company’s strategic growth plan. We conducted the feasibility study including conceptual layouts, estimates of probable cost, a ranking of weighted evaluation factors and a summary of recommendations.

• iDesign worked hands-on in partnership with end users to develop the overall building layout followed by detailed lab plans, including support spaces, isolator unit, controlled temperature stability chambers, retains storage, pilot plant and hazardous materials storage.  

• The campus received successful GMP/GLP audits conducted on the site by the FDA biologics division and the European Medicines Agency.

“The new Quality Testing Laboratory and Development Center was the key asset to attracting PAR Pharmaceutical and securing the purchase agreement.” (paraphrased)

- Stuart Hinchen, co-founder, Chief Executive Officer and investor of JHP as communicated by Bryan Kistner, Pharmaceutical Operational & Engineering Business Leader